Market pessimism towards Gilead Sciences is shown by its low...
Market pessimism towards Gilead Sciences is shown by its low P/S ratio, reflecting concerns about its growth. This view stems from poor revenue growth compared to the more vibrant biotech sector.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000292b6cca4de0a6.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment